These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 14674012)

  • 1. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission.
    Cavill D; Waterman SA; Gordon TP
    Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to calcium channels in type 1 diabetes mediate autonomic dysfunction by different mechanisms in colon and bladder and are neutralized by antiidiotypic antibodies.
    Wan EC; Gordon TP; Jackson MW
    J Autoimmun; 2008 Aug; 31(1):66-72. PubMed ID: 18472396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome.
    Smith AJ; Jackson MW; Wang F; Cavill D; Rischmueller M; Gordon TP
    Hum Immunol; 2005 Apr; 66(4):411-6. PubMed ID: 15866705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome.
    Cavill D; Waterman SA; Gordon TP
    Scand J Immunol; 2004 Mar; 59(3):261-6. PubMed ID: 15030576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA; Gordon TP; Rischmueller M
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.
    Wang F; Jackson MW; Maughan V; Cavill D; Smith AJ; Waterman SA; Gordon TP
    Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.
    Cha S; Singson E; Cornelius J; Yagna JP; Knot HJ; Peck AB
    J Rheumatol; 2006 Feb; 33(2):296-306. PubMed ID: 16465661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effects of antimuscarinic autoantibodies in the sera of primary Sjogren syndrome patients on the gastrointestinal motility.
    Park K; Park S; Jackson MW
    Mol Immunol; 2013 Dec; 56(4):583-7. PubMed ID: 23911416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.
    Dietrich G; Kazatchkine MD
    J Clin Invest; 1990 Mar; 85(3):620-5. PubMed ID: 2312717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R.
    Schegg V; Vogel M; Didichenko S; Stadler MB; Beleznay Z; Gadola S; Sengupta C; Stadler BM; Miescher SM
    Biologicals; 2008 Jul; 36(4):213-22. PubMed ID: 18249005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
    Dawson LJ; Stanbury J; Venn N; Hasdimir B; Rogers SN; Smith PM
    Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.
    Koo NY; Li J; Hwang SM; Choi SY; Lee SJ; Oh SB; Kim JS; Lee EB; Song YW; Park K
    Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
    Park K; Haberberger RV; Gordon TP; Jackson MW
    Arthritis Rheum; 2011 May; 63(5):1426-34. PubMed ID: 21312189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.
    Rossi F; Kazatchkine MD
    J Immunol; 1989 Dec; 143(12):4104-9. PubMed ID: 2592768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay.
    Gao J; Cha S; Jonsson R; Opalko J; Peck AB
    Arthritis Rheum; 2004 Aug; 50(8):2615-21. PubMed ID: 15334476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.
    Rossi F; Sultan Y; Kazatchkine MD
    Clin Exp Immunol; 1988 Nov; 74(2):311-6. PubMed ID: 3147154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.
    Dawson LJ; Allison HE; Stanbury J; Fitzgerald D; Smith PM
    Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and V(H) sequences of human monoclonal anti-F(ab')(2) autoantibodies from normals and Sjögren's syndrome patients.
    Elagib KE; Børretzen M; Vatn I; Natvig JB; Thompson KM
    Clin Immunol; 2001 Jan; 98(1):62-9. PubMed ID: 11141328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
    Namkoong E; Lee SW; Kim N; Choi Y; Park K
    Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.